Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : PFE save search
Pfizer and Ionis announce discontinuation of vupanorsen clinical development program
Published: 2022-01-31 (Crawled : 12:30) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.61%
H: 0.26%
C: -2.43%
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: -10.54%
H: 12.88%
C: 12.21%
program
Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults
Published: 2022-03-15 (Crawled : 23:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.56%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 1.63%
H: 11.55%
C: 11.21%
covid-19 covid authorization vaccine tiona merge order emergency use authorization
Cellectis Supplements the Announcement of the Pricing of Follow-On Offering with Allocation of Share Capital Information
Published: 2023-02-03 (Crawled : 15:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.03%
H: 0.08%
C: -0.67%
CLLS | $2.47 0.4% 12K
|
Health Technology
|
| O: -30.67%
H: 12.39%
C: 11.06%
offering announcement
Akero Therapeutics Announces Two Financing Transactions with Pfizer Inc. and Hercules Capital, Inc. Providing Access to Up To $125 Million
Published: 2022-06-16 (Crawled : 11:00) - ir.akerotx.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.16%
H: 0.0%
C: 0.0%
HTGC F | $18.46 1.15% 0.38% 660K
|
Finance
|
| O: -2.88%
H: 1.33%
C: 0.08%
AKRO | $20.76 1.22% 1.2% 790K
|
Health Technology
|
| O: 17.77%
H: 14.88%
C: 10.2%
therapeutics
Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss
Published: 2024-03-12 (Crawled : 12:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.21%
H: 0.11%
C: -1.06%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.9%
H: 2.03%
C: 1.89%
VERU | $1.305 -8.1% -8.81% 2.6M
|
Health Technology
|
| O: -0.53%
H: 2.22%
C: -3.59%
ALT | $6.91 0.29% 0.29% 3.6M
|
Commercial Services
|
| O: 0.3%
H: 11.41%
C: 9.8%
medical program
Lineage Cell Therapeutics Appoints Jill Howe as Chief Financial Officer
Published: 2022-10-31 (Crawled : 15:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.74%
H: 0.65%
C: -1.13%
GOSS 4 | $0.7837 -2.77% -2.85% 670K
|
Health Technology
|
| O: -0.38%
H: 6.05%
C: 5.71%
LCTX | $1.15 -4.17% 0.0% 1.1M
|
Health Technology
|
| O: 0.79%
H: 10.24%
C: 8.66%
therapeutics financial
Follow-Up Data from Phase 3 Trial Of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age
Published: 2021-11-22 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: -0.23%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -1.72%
H: 1.02%
C: 0.49%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 7.04%
H: 8.12%
C: 7.96%
covid vaccine phase 3 trial
Arvinas Announces Oversubscribed $350 Million Private Placement
Published: 2023-11-27 (Crawled : 12:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: -1.98%
ARVN | $34.78 1.43% 1.41% 940K
|
Health Technology
|
| O: 2.51%
H: 11.93%
C: 7.54%
Biotechs Step Up Development Activities as U.S. Government Prioritizes Availability Of COVID-19 Vaccines
Published: 2021-03-15 (Crawled : 13:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.2%
H: 1.2%
C: 1.14%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.09%
H: 0.57%
C: 0.42%
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 0.27%
H: 7.58%
C: 6.95%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: -0.16%
H: 5.18%
C: 5.04%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.69%
H: 4.0%
C: 3.74%
covid biotech vaccine iot covid-19
ZyVersa Therapeutics Appoints Three New Board Members
Published: 2023-01-05 (Crawled : 15:00) - prnewswire.com
FWBI | $2.59 -8.8% -9.65% 83K
|
Manufacturing
|
| O: 1.82%
H: 14.29%
C: 2.68%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.8%
H: 0.52%
C: -0.14%
AXGN | $6.51 -0.61% -0.61% 330K
|
Health Technology
|
| O: -1.33%
H: 7.56%
C: 6.95%
therapeutics
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-03-25 (Crawled : 15:49) - fda.gov
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.11%
H: 0.39%
C: 0.06%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.46%
H: 1.46%
C: 1.15%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 1.12%
H: 0.0%
C: -0.33%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.16%
H: 1.21%
C: 0.95%
SUPN | $29.43 1.94% 1.9% 360K
|
Health Technology
|
| O: -0.32%
H: 5.23%
C: 4.43%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.89%
H: 0.5%
C: 0.41%
OTIC | $0.077
|
Health Technology
|
| O: -1.88%
H: 2.3%
C: 0.0%
OMER | $3.045 -5.14% -5.42% 390K
|
Health Technology
|
| O: -1.44%
H: 3.5%
C: 2.24%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.67%
H: 0.15%
C: -1.22%
BMRN | $88.68 -1.54% -1.57% 1.8M
|
Health Technology
|
| O: -0.72%
H: 1.06%
C: 0.76%
BCRX | $4.44 -1.33% -1.35% 4.7M
|
Health Technology
|
| O: -4.08%
H: 7.03%
C: 6.04%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.64%
H: 0.2%
C: -0.32%
Arvinas Reports First Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-05-05 (Crawled : 11:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.39%
H: 0.31%
C: 0.29%
ARVN | $34.78 1.43% 1.41% 940K
|
Health Technology
|
| O: 2.04%
H: 5.9%
C: 5.46%
update financial results
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years
Published: 2022-12-08 (Crawled : 16:00) - globenewswire.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -0.76%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.5%
H: 0.16%
C: 0.16%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.12%
H: 3.36%
C: 3.19%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.32%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.37%
H: 5.31%
C: 5.26%
covid-19 fda children vaccine authorization
Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates
Published: 2022-04-07 (Crawled : 11:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.7%
H: 5.54%
C: 5.07%
respiratory virus
Global CAR T-Cell Therapy Market Analysis Report 2023: Drug type, Indication, Target Antigen, End-user and Region - Forecast to 2030
Published: 2024-01-24 (Crawled : 17:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.39%
H: 0.82%
C: -0.74%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.22%
H: 0.43%
C: -0.39%
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: -63.33%
H: 263.64%
C: 127.27%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.1%
H: 0.43%
C: -0.04%
AUTL | $4.51 -6.04% -6.43% 1.4M
|
Health Technology
|
| O: -0.91%
H: 11.52%
C: 4.94%
drug report t-cell global therapy market
Arena Pharmaceuticals INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arena Pharmaceuticals, Inc. - ARNA
Published: 2021-12-15 (Crawled : 05:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 2.56%
H: 5.0%
C: 4.79%
als
Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older
Published: 2022-10-13 (Crawled : 11:00) - globenewswire.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -4.1%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.78%
H: 0.0%
C: 0.0%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.64%
H: 3.35%
C: 2.92%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.67%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -2.2%
H: 6.32%
C: 4.76%
trial positive
Deciphera Pharmaceuticals Announces First Quarter 2023 Financial Results
Published: 2023-05-03 (Crawled : 12:20) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.36%
H: 0.48%
C: -1.91%
DCPH | $14.69 3.23% 3.13% 390K
|
Health Technology
|
| O: -6.99%
H: 7.22%
C: 4.74%
pharmaceuticals financial results
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-06-21 (Crawled : 00:00) - fda.gov
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.18%
H: 1.54%
C: 1.39%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.25%
H: 2.13%
C: 1.63%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.21%
H: 0.83%
C: 0.33%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.5%
H: 1.37%
C: 0.91%
XERS | $1.73 -1.7% -1.73% 2M
|
Health Technology
|
| O: 0.24%
H: 0.73%
C: -4.13%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.32%
H: 0.17%
C: -0.13%
OTIC | $0.077
|
Health Technology
|
| O: 0.0%
H: 3.98%
C: -1.33%
OMER | $3.045 -5.14% -5.42% 390K
|
Health Technology
|
| O: 1.39%
H: 0.79%
C: 0.33%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.57%
H: 0.86%
C: 0.54%
BCRX | $4.44 -1.33% -1.35% 4.7M
|
Health Technology
|
| O: 0.5%
H: 4.88%
C: 4.7%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.4%
H: 0.53%
C: 0.25%
Myovant Sciences and Pfizer Announce Positive One-Year Data from Phase 3 SPIRIT Extension Study of Once-Daily Relugolix Combination Therapy in Women with Endometriosis
Published: 2021-01-26 (Crawled : 12:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.03%
H: 0.89%
C: 0.11%
MYOV | $26.98 -0.04% 0.0% 0
|
Health Technology
|
| O: 4.44%
H: 9.52%
C: 4.67%
positive therapy phase 3
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.